Resveratrol loaded solid lipid nanoparticles attenuate mitochondrial oxidative stress in vascular dementia by activating Nrf2/HO-1 pathway

Neurochemistry International

Volumn 112, Issue , 2018, Pages 239-254

  Yadav, Aarti ^a   Sunkaria, Aditya ^a   Singhal, Nitin ^b   Sandhir, Rajat ^a  

^a PANJAB UNIVERSITY   (India)

^b NATIONAL AGRI FOOD BIOTECHNOLOGY INSTITUTE   (India)

Author keywords

Antioxidants; Nanomedicine; Oxidative stress; Resveratrol; Solid lipid nanoparticles; Vascular dementia

Indexed keywords

ANTIOXIDANT; DRUG CARRIER; HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; LIPOSOME; MEMBRANE PROTEIN; NANOPARTICLE; NFE2L2 PROTEIN, MOUSE; REACTIVE OXYGEN METABOLITE; RESVERATROL; TRANSCRIPTION FACTOR NRF2;

AGONISTS; ANIMAL; DRUG EFFECT; MALE; METABOLISM; MITOCHONDRION; MULTIINFARCT DEMENTIA; OXIDATIVE STRESS; PHYSIOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; DEMENTIA, VASCULAR; DRUG CARRIERS; HEME OXYGENASE-1; LIPOSOMES; MALE; MEMBRANE PROTEINS; MITOCHONDRIA; NANOPARTICLES; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RESVERATROL; SIGNAL TRANSDUCTION;

EID: 85028316451     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2017.08.001     Document Type: Article

References (95)

1. Ahmed, T., Javed, S., Tariq, A., Samec, D., Tejada, S., Nabavi, S.F., Braidy, N., Nabavi, S.M., Resveratrol and Alzheimer's disease: mechanistic insights. Mol. Neurobiol. 54 (2017), 2622–2635.
2. Alfieri, A., Srivastava, S., Siow, R.C., Modo, M., Fraser, P.A., Mann, G.E., Targeting the Nrf2-Keap1 antioxidant defence pathway for neurovascular protection in stroke. J. Physiol. 589 (2011), 4125–4136.
3. Aliev, G., Gasimov, E., Obrenovich, M.E., Fischbach, K., Shenk, J.C., Smith, M.A., Perry, G., Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels: implication in the pathogenesis of Alzheimer's disease. Vasc. Health Risk Manag. 4 (2008), 721–730.
4. Andreyev, A.Y., Kushnareva, Y.E., Starkov, A.A., Mitochondrial metabolism of reactive oxygen species. Biochem. (Mosc) 70 (2005), 200–214.
5. Atalay, T., Gulsen, I., Colcimen, N., Alp, H.H., Sosuncu, E., Alaca, I., Ak, H., Ragbetli, M.C., Resveratrol treatment prevents hippocamal neurodegeneration in a rodent model of traumatic brain injury. Turk Neurosurg., 2016, 10.5137/1019-5149.JTN.17249-16.2 [Epub ahead of print].
6. Aytac, E., Seymen, H.O., Uzun, H., Dikmen, G., Altug, T., Effects of iloprost on visual evoked potentials and brain tissue oxidative stress after bilateral common carotid artery occlusion. Prostagl. Leukot. Essent. Fat. Acids 74 (2006), 373–378.
7. Baranova, O., Miranda, L.F., Pichiule, P., Dragatsis, I., Johnson, R.S., Chavez, J.C., Neuron-specific inactivation of the hypoxia inducible factor 1 alpha increases brain injury in a mouse model of transient focal cerebral ischemia. J. Neurosci. 27 (2007), 6320–6332.
8. Baur, J.A., Pearson, K.J., Price, N.L., Jamieson, H.A., Lerin, C., Kalra, A., Prabhu, V.V., Allard, J.S., Lopez-Lluch, G., Lewis, K., Pistell, P.J., Poosala, S., Becker, K.G., Boss, O., Gwinn, D., Wang, M., Ramaswamy, S., Fishbein, K.W., Spencer, R.G., Lakatta, E.G., Le Couteur, D., Shaw, R.J., Navas, P., Puigserver, P., Ingram, D.K., de Cabo, R., Sinclair, D.A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444 (2006), 337–342.
9. Bellaver, B., Souza, D.G., Bobermin, L.D., Souza, D.O., Goncalves, C.A., Quincozes-Santos, A., Resveratrol protects hippocampal astrocytes against LPS-induced neurotoxicity through HO-1, p38 and ERK pathways. Neurochem. Res. 40 (2015), 1600–1608.
10. Bobermin, L.D., Wartchow, K.M., Flores, M.P., Leite, M.C., Quincozes-Santos, A., Goncalves, C.A., Ammonia-induced oxidative damage in neurons is prevented by resveratrol and lipoic acid with participation of heme oxygenase 1. Neurotoxicology 49 (2015), 28–35.
11. Briede, J., Duburs, G., Protective effect of cerebrocrast on rat brain ischaemia induced by occlusion of both common carotid arteries. Cell Biochem. Funct. 25 (2007), 203–210.
12. Cai, Z.Y., Yan, Y., Sun, S.Q., Zhang, J., Huang, L.G., Yan, N., Wu, F., Li, J.Y., Minocycline attenuates cognitive impairment and restrains oxidative stress in the hippocampus of rats with chronic cerebral hypoperfusion. Neurosci. Bull. 24 (2008), 305–313.
13. Cheng, L., Jin, Z., Zhao, R., Ren, K., Deng, C., Yu, S., Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway. Int. J. Clin. Exp. Med. 8 (2015), 10420–10428.
14. Cui, Y., Zhang, B., Zhang, R., Li, C., Zhao, Y., Ren, Y., Yang, J., Effects of resveratrol on morphology and oxidative stress of brain tissues in aging mice. Wei Sheng Yan Jiu 42 (2013), 995–998 1003.
15. Du, J., Ma, M., Zhao, Q., Fang, L., Chang, J., Wang, Y., Fei, R., Song, X., Mitochondrial bioenergetic deficits in the hippocampi of rats with chronic ischemia-induced vascular dementia. Neuroscience 231 (2013), 345–352.
16. Du, Y., Zhang, X., Ji, H., Liu, H., Li, S., Li, L., Probucol and atorvastatin in combination protect rat brains in MCAO model: upregulating Peroxiredoxin2, Foxo3a and Nrf2 expression. Neurosci. Lett. 509 (2012), 110–115.
17. Enciu, A.M., Constantinescu, S.N., Popescu, L.M., Muresanu, D.F., Popescu, B.O., Neurobiology of vascular dementia. J. Aging Res., 2011, 2011 401604.
18. Frozza, R.L., Bernardi, A., Hoppe, J.B., Meneghetti, A.B., Battastini, A.M., Pohlmann, A.R., Guterres, S.S., Salbego, C., Lipid-core nanocapsules improve the effects of resveratrol against Abeta-induced neuroinflammation. J. Biomed. Nanotechnol. 9 (2013), 2086–2104.
19. Gaur, V., Kumar, A., Protective effect of desipramine, venlafaxine and trazodone against experimental animal model of transient global ischemia: possible involvement of NO-cGMP pathway. Brain Res. 1353 (2010), 204–212.
20. Gaur, V., Kumar, A., Effect of nonselective and selective COX-2 inhibitors on memory dysfunction, glutathione system, and tumor necrosis factor alpha level against cerebral ischemia reperfusion injury. Drug Chem. Toxicol. 35 (2012), 218–224.
21. Ghosh, S., Das, N., Mandal, A.K., Dungdung, S.R., Sarkar, S., Mannosylated liposomal cytidine 5’ diphosphocholine prevent age related global moderate cerebral ischemia reperfusion induced mitochondrial cytochrome c release in aged rat brain. Neuroscience 171 (2010), 1287–1299.
22. Girbovan, C., Kent, P., Merali, Z., Plamondon, H., Dose-related effects of chronic resveratrol administration on neurogenesis, angiogenesis, and corticosterone secretion are associated with improved spatial memory retention following global cerebral ischemia. Nutr. Neurosci. 19 (2016), 352–368.
23. Gocmez, S.S., Gacar, N., Utkan, T., Gacar, G., Scarpace, P.J., Tumer, N., Protective effects of resveratrol on aging-induced cognitive impairment in rats. Neurobiol. Learn Mem. 131 (2016), 131–136.
24. Godman, C.A., Chheda, K.P., Hightower, L.E., Perdrizet, G., Shin, D.G., Giardina, C., Hyperbaric oxygen induces a cytoprotective and angiogenic response in human microvascular endothelial cells. Cell Stress Chaperones 15 (2010), 431–442.
25. Gokce, E.H., Korkmaz, E., Dellera, E., Sandri, G., Bonferoni, M.C., Ozer, O., Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications. Int. J. Nanomedicine 7 (2012), 1841–1850.
26. Gorelick, P.B., Scuteri, A., Black, S.E., Decarli, C., Greenberg, S.M., Iadecola, C., Launer, L.J., Laurent, S., Lopez, O.L., Nyenhuis, D., Petersen, R.C., Schneider, J.A., Tzourio, C., Arnett, D.K., Bennett, D.A., Chui, H.C., Higashida, R.T., Lindquist, R., Nilsson, P.M., Roman, G.C., Sellke, F.W., Seshadri, S., Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke 42 (2011), 2672–2713.
27. Guo, Y.J., Dong, S.Y., Cui, X.X., Feng, Y., Liu, T., Yin, M., Kuo, S.H., Tan, E.K., Zhao, W.J., Wu, Y.C., Resveratrol alleviates MPTP-induced motor impairments and pathological changes by autophagic degradation of alpha-synuclein via SIRT1-deacetylated LC3. Mol. Nutr. Food Res. 60 (2016), 2161–2175.
28. Haase, V.H., Regulation of erythropoiesis by hypoxia-inducible factors. Blood Rev. 27 (2013), 41–53.
29. Hissin, P.J., Hilf, R., A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 74 (1976), 214–226.
30. Huang, H., Tu, R., Liu, F., Feng, D., Liu, W., Yuan, W., Cheng, X., Cui, L., Effects of resveratrol on Nrf2 signal pathway of chronic lead-exposed mouse brain tissue. Wei Sheng Yan Jiu 44 (2015), 954–958.
31. Jardim, F.R., de Rossi, F.T., Nascimento, M.X., da Silva Barros, R.G., Borges, P.A., Prescilio, I.C., de Oliveira, M.R., Resveratrol and brain mitochondria: a review. Mol. Neurobiol., 2017, 10.1007/s12035-017-0448-z [Epub ahead of print].
32. Jellinger, K.A., The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol. 113 (2007), 349–388.
33. Jin, W., Jia, Y., Huang, L., Wang, T., Wang, H., Dong, Y., Zhang, H., Fan, M., Lv, P., Lipoxin A4 methyl ester ameliorates cognitive deficits induced by chronic cerebral hypoperfusion through activating ERK/Nrf2 signaling pathway in rats. Pharmacol. Biochem. Behav. 124 (2014), 145–152.
34. Jing, Z., Shi, C., Zhu, L., Xiang, Y., Chen, P., Xiong, Z., Li, W., Ruan, Y., Huang, L., Chronic cerebral hypoperfusion induces vascular plasticity and hemodynamics but also neuronal degeneration and cognitive impairment. J. Cereb. Blood Flow. Metab. 35 (2015), 1249–1259.
35. Jose, S., Anju, S.S., Cinu, T.A., Aleykutty, N.A., Thomas, S., Souto, E.B., In vivo pharmacokinetics and biodistribution of resveratrol-loaded solid lipid nanoparticles for brain delivery. Int. J. Pharm. 474 (2014), 6–13.
36. Karuppagounder, S.S., Ratan, R.R., Hypoxia-inducible factor prolyl hydroxylase inhibition: robust new target or another big bust for stroke therapeutics?. J. Cereb. Blood Flow. Metab. 32 (2012), 1347–1361.
37. Kensler, T.W., Wakabayashi, N., Biswal, S., Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu. Rev. Pharmacol. Toxicol. 47 (2007), 89–116.
38. Khan, M.M., Ahmad, A., Ishrat, T., Khan, M.B., Hoda, M.N., Khuwaja, G., Raza, S.S., Khan, A., Javed, H., Vaibhav, K., Islam, F., Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res. 1328 (2010), 139–151.
39. Kono, Y., Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Arch. Biochem. Biophys. 186 (1978), 189–195.
40. Kwon, K.J., Kim, H.J., Shin, C.Y., Han, S.H., Melatonin potentiates the neuroprotective properties of resveratrol against beta-amyloid-induced neurodegeneration by modulating AMP-activated protein kinase pathways. J. Clin. Neurol. 6 (2010), 127–137.
41. Lambert, C.M., Roy, M., Robitaille, G.A., Richard, D.E., Bonnet, S., HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism. Cardiovasc Res. 88 (2010), 196–204.
42. Lee, J.W., Bae, S.H., Jeong, J.W., Kim, S.H., Kim, K.W., Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp. Mol. Med. 36 (2004), 1–12.
43. Lei, X., Lei, L., Zhang, Z., Cheng, Y., Neuroprotective effects of lycopene pretreatment on transient global cerebral ischemiareperfusion in rats: the role of the Nrf2/HO1 signaling pathway. Mol. Med. Rep. 13 (2016), 412–418.
44. Levine, R.L., Garland, D., Oliver, C.N., Amici, A., Climent, I., Lenz, A.G., Ahn, B.W., Shaltiel, S., Stadtman, E.R., Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186 (1990), 464–478.
45. Lippacher, A., Muller, R.H., Mader, K., Preparation of semisolid drug carriers for topical application based on solid lipid nanoparticles. Int. J. Pharm. 214 (2001), 9–12.
46. Lippacher, A., Muller, R.H., Mader, K., Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties. Eur. J. Pharm. Biopharm. 53 (2002), 155–160.
47. Liu, G.S., Zhang, Z.S., Yang, B., He, W., Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. Life Sci. 91 (2012), 872–877.
48. Liu, H., Zhang, J., Cerebral hypoperfusion and cognitive impairment: the pathogenic role of vascular oxidative stress. Int. J. Neurosci. 122 (2012), 494–499.
49. Loureiro, J.A., Andrade, S., Duarte, A., Neves, A.R., Queiroz, J.F., Nunes, C., Sevin, E., Fenart, L., Gosselet, F., Coelho, M.A., Pereira, M.C., Resveratrol and grape extract-loaded solid lipid nanoparticles for the treatment of Alzheimer's disease. Molecules, 22, 2017.
50. Lowry, O.H., Rosebrough, N.J., Farr, A.L., Randall, R.J., Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951), 265–275.
51. Ma, X., Sun, Z., Liu, Y., Jia, Y., Zhang, B., Zhang, J., Resveratrol improves cognition and reduces oxidative stress in rats with vascular dementia. Neural Regen. Res. 8 (2013), 2050–2059.
52. Moretti, R., Torre, P., Antonello, R.M., Cattaruzza, T., Cazzato, G., Bava, A., Frontal lobe dementia and subcortical vascular dementia: a neuropsychological comparison. Psychol. Rep. 96 (2005), 141–151.
53. Morris, R., Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984), 47–60.
54. Muralikrishna Adibhatla, R., Hatcher, J.F., Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic. Biol. Med. 40 (2006), 376–387.
55. Neves, A.R., Lucio, M., Martins, S., Lima, J.L., Reis, S., Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailability. Int. J. Nanomedicine 8 (2013), 177–187.
56. Neves, A.R., Queiroz, J.F., Reis, S., Brain-targeted delivery of resveratrol using solid lipid nanoparticles functionalized with apolipoprotein E. J. Nanobiotechnology, 14, 2016, 27.
57. Ohkawa, H., Ohishi, N., Yagi, K., Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95 (1979), 351–358.
58. Ozacmak, V.H., Sayan-Ozacmak, H., Barut, F., Chronic treatment with resveratrol, a natural polyphenol found in grapes, alleviates oxidative stress and apoptotic cell death in ovariectomized female rats subjected to chronic cerebral hypoperfusion. Nutr. Neurosci. 19 (2016), 176–186.
59. Pandita, D., Kumar, S., Poonia, N., Lather, V., Solid lipid nanoparticles enhance oral bioavailability of resevretrol, a natural polyphenol. Food Res. Int. 62 (2014), 1165–1174.
60. Pardeshi, C., Rajput, P., Belgamwar, V., Tekade, A., Patil, G., Chaudhary, K., Sonje, A., Solid lipid based nanocarriers: an overview. Acta Pharm. 62 (2012), 433–472.
61. Pasinetti, G.M., Wang, J., Marambaud, P., Ferruzzi, M., Gregor, P., Knable, L.A., Ho, L., Neuroprotective and metabolic effects of resveratrol: therapeutic implications for Huntington's disease and other neurodegenerative disorders. Exp. Neurol. 232 (2011), 1–6.
62. Peng, B., Zhao, P., Lu, Y.P., Chen, M.M., Sun, H., Wu, X.M., Zhu, L., Z-ligustilide activates the Nrf2/HO-1 pathway and protects against cerebral ischemia-reperfusion injury in vivo and in vitro. Brain Res. 1520 (2013), 168–177.
63. Peters, O., Back, T., Lindauer, U., Busch, C., Megow, D., Dreier, J., Dirnagl, U., Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. J. Cereb. Blood Flow. Metab. 18 (1998), 196–205.
64. Pfaffl, M.W., A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res., 29, 2001, e45.
65. Pineda-Ramirez, N., Gutierrez Aguilar, G.F., Espinoza-Rojo, M., Aguilera, P., Current evidence for AMPK activation involvement on resveratrol-induced neuroprotection in cerebral ischemia. Nutr. Neurosci., 2017, 1–19.
66. Plaschke, K., Aspects of ageing in chronic cerebral oligaemia. Mechanisms of degeneration and compensation in rat models. J. Neural Transm. (Vienna) 112 (2005), 393–413.
67. Plaschke, K., Weigand, M.A., Michel, A., Martin, E., Bardenheuer, H.J., Permanent cerebral hypoperfusion: ‘preconditioning-like’ effects on rat energy metabolism towards acute systemic hypotension. Brain Res. 858 (2000), 363–370.
68. Puka-Sundvall, M., Wallin, C., Gilland, E., Hallin, U., Wang, X., Sandberg, M., Karlsson, J., Blomgren, K., Hagberg, H., Impairment of mitochondrial respiration after cerebral hypoxia-ischemia in immature rats: relationship to activation of caspase-3 and neuronal injury. Brain Res. Dev. Brain Res. 125 (2000), 43–50.
69. Reagan-Shaw, S., Nihal, M., Ahmad, N., Dose translation from animal to human studies revisited. FASEB J. 22 (2008), 659–661.
70. Ren, J., Fan, C., Chen, N., Huang, J., Yang, Q., Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats. Neurochem. Res. 36 (2011), 2352–2362.
71. Roman, G.C., Royall, D.R., Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis. Assoc. Disord. 13:Suppl. 3 (1999), S69–S80.
72. Sandhir, R., Yadav, A., Mehrotra, A., Sunkaria, A., Singh, A., Sharma, S., Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington's disease. Neuromolecular Med. 16 (2014), 106–118.
73. Sandhir, R., Yadav, A., Sunkaria, A., Singhal, N., Nano-antioxidants: an emerging strategy for intervention against neurodegenerative conditions. Neurochem. Int. 89 (2015), 209–226.
74. Sanna, V., Siddiqui, I.A., Sechi, M., Mukhtar, H., Resveratrol-loaded nanoparticles based on poly(epsilon-caprolactone) and poly(D,L-lactic-co-glycolic acid)-poly(ethylene glycol) blend for prostate cancer treatment. Mol. Pharm. 10 (2013), 3871–3881.
75. Saxena, A.K., Abdul-Majeed, S.S., Gurtu, S., Mohamed, W.M., Investigation of redox status in chronic cerebral hypoperfusion-induced neurodegeneration in rats. Appl. Transl. Genom. 5 (2015), 30–32.
76. Semenza, G.L., Regulation of physiological responses to continuous and intermittent hypoxia by hypoxia-inducible factor 1. Exp. Physiol. 91 (2006), 803–806.
77. Siddiqui, M.A., Kashyap, M.P., Kumar, V., Al-Khedhairy, A.A., Musarrat, J., Pant, A.B., Protective potential of trans-resveratrol against 4-hydroxynonenal induced damage in PC12 cells. Toxicol In Vitro 24 (2010), 1592–1598.
78. Simao, F., Matte, A., Pagnussat, A.S., Netto, C.A., Salbego, C.G., Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3beta and CREB through PI3-K/Akt pathways. Eur. J. Neurosci. 36 (2012), 2899–2905.
79. Spijker, S., Dissection of Rodent Brain Regions. Li, K.W., (eds.) Neuroproteomics, 2011, Humana Press, New York, 13–26.
80. Subedi, R.K., Kang, K.W., Choi, H.K., Preparation and characterization of solid lipid nanoparticles loaded with doxorubicin. Eur. J. Pharm. Sci. 37 (2009), 508–513.
81. Summerlin, N., Soo, E., Thakur, S., Qu, Z., Jambhrunkar, S., Popat, A., Resveratrol nanoformulations: challenges and opportunities. Int. J. Pharm. 479 (2015), 282–290.
82. Sun, Z.K., Ma, X.R., Jia, Y.J., Liu, Y.R., Zhang, J.W., Zhang, B.A., Effects of resveratrol on apoptosis in a rat model of vascular dementia. Exp. Ther. Med. 7 (2014), 843–848.
83. Teskac, K., Kristl, J., The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol. Int. J. Pharm. 390 (2010), 61–69.
84. Towbin, H., Staehelin, T., Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979. Biotechnology 24 (1992), 145–149.
85. Wan, D., Zhou, Y., Wang, K., Hou, Y., Hou, R., Ye, X., Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats. Brain Res. Bull. 121 (2016), 255–262.
86. Wang, H., Joseph, J.A., Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 27 (1999), 612–616.
87. Wenzel, E., Somoza, V., Metabolism and bioavailability of trans-resveratrol. Mol. Nutr. Food Res. 49 (2005), 472–481.
88. Yabuki, Y., Fukunaga, K., Oral administration of glutathione improves memory deficits following transient brain ischemia by reducing brain oxidative stress. Neuroscience 250 (2013), 394–407.
89. Yang, K.Y., Lin, L.C., Tseng, T.Y., Wang, S.C., Tsai, T.H., Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 853 (2007), 183–189.
90. Yousuf, S., Atif, F., Ahmad, M., Hoda, N., Ishrat, T., Khan, B., Islam, F., Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 1250 (2009), 242–253.
91. Zasler, N.D., Martelli, M.F., Jacobs, H.E., Neurobehavioral disorders. Handb. Clin. Neurol. 110 (2013), 377–388.
92. Zhai, X., Chen, X., Shi, J., Shi, D., Ye, Z., Liu, W., Li, M., Wang, Q., Kang, Z., Bi, H., Sun, X., Lactulose ameliorates cerebral ischemia-reperfusion injury in rats by inducing hydrogen by activating Nrf2 expression. Free Radic. Biol. Med. 65 (2013), 731–741.
93. Zhang, M., Li, W., Yu, L., Wu, S., The suppressive effect of resveratrol on HIF-1alpha and VEGF expression after warm ischemia and reperfusion in rat liver. PLoS One, 9, 2014, e109589.
94. Zhao, R.R., Xu, F., Xu, X.C., Tan, G.J., Liu, L.M., Wu, N., Zhang, W.Z., Liu, J.X., Effects of alpha-lipoic acid on spatial learning and memory, oxidative stress, and central cholinergic system in a rat model of vascular dementia. Neurosci. Lett. 587 (2015), 113–119.
95. Zito, G., Polimanti, R., Panetta, V., Ventriglia, M., Salustri, C., Siotto, M.C., Moffa, F., Altamura, C., Vernieri, F., Lupoi, D., Cassetta, E., Rossini, P.M., Squitti, R., Antioxidant status and APOE genotype as susceptibility factors for neurodegeneration in Alzheimer's disease and vascular dementia. Rejuvenation Res. 16 (2013), 51–56.